| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Animal: RNA Viruses |
Clinical Laboratory, Department of Internal Veterinary Medicine, Faculty of Veterinary Medicine, University of Zurich, Winterthurerstrasse 260, CH-8057 Zurich, Switzerland1
Author for correspondence: Hans Lutz. Fax +41 1 63 58 906. e-mail hanslutz{at}vetklinik.unizh.ch
Feline leukaemia virus (FeLV) infection in domestic cats can vary in its outcome (persistent, transient, no infection) for reasons that are not entirely known. It was hypothesized that the initial virus and provirus load could significantly influence the course of retrovirus infection. To determine the role of provirus loads, two methods of PCR, a nested PCR and a fluorogenic probe-based (TaqMan) real-time quantitative PCR, which were specific to the U3 region of FeLV-A were established. FeLV provirus in naturally and experimentally infected cats was then measured. Only 3 weeks after experimental FeLV-A infection, persistently infected cats demonstrated higher provirus loads and lower humoral immune responses than cats that had overcome antigenaemia. Lower initial provirus loads were associated with successful humoral immune responses. Unexpectedly, provirus in the buffy-coat cells of two cats that tested negative for the p27 antigen (a marker for viraemia) was also detected. In 597 Swiss cats, comparison of p27 antigen levels with PCR results revealed broad agreement. However, similar to the experimental situation, a significant number of animals (10%) was negative for the p27 antigen and FeLV-positive by PCR. These cats had a mean provirus load 300-fold lower than that of animals testing positive for the p27 antigen. In conclusion, an association between the provirus load and the outcome of FeLV infection was found. Detection of provirus carriers should contribute to further the control of FeLV. In addition, quantification of provirus loads will lead to a better understanding of FeLV pathogenesis and anti-retrovirus protective mechanisms.
This article has been cited by other articles:
|
|
 |
|
  F. M. Coelho, M. R. Q. Bomfim, F. de Andrade Caxito, N. A. Ribeiro, M. M. Luppi, E. A. Costa, M. E. Oliveira, F. G. Da Fonseca, and M. Resende Naturally occurring feline leukemia virus subgroup A and B infections in urban domestic cats J. Gen. Virol., November 1, 2008; 89(11): 2799 - 2805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Cunningham, M. A. Brown, D. B. Shindle, S. P. Terrell, K. A. Hayes, B. C. Ferree, R. T. McBride, E. L. Blankenship, D. Jansen, S. B. Citino, et al. EPIZOOTIOLOGY AND MANAGEMENT OF FELINE LEUKEMIA VIRUS IN THE FLORIDA PUMA J. Wildl. Dis., July 1, 2008; 44(3): 537 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Filoni, J. L. Catao-Dias, G. Bay, E. L. Durigon, R. S. P. Jorge, H. Lutz, and R. Hofmann-Lehmann First Evidence of Feline Herpesvirus, Calicivirus, Parvovirus, and Ehrlichia Exposure in Brazilian Free-ranging Felids. J. Wildl. Dis., April 1, 2006; 42(2): 470 - 477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Gomes-Keller, E. Gonczi, R. Tandon, F. Riondato, R. Hofmann-Lehmann, M. L. Meli, and H. Lutz Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J. Clin. Microbiol., March 1, 2006; 44(3): 916 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Willi, F. S. Boretti, V. Cattori, S. Tasker, M. L. Meli, C. Reusch, H. Lutz, and R. Hofmann-Lehmann Identification, Molecular Characterization, and Experimental Transmission of a New Hemoplasma Isolate from a Cat with Hemolytic Anemia in Switzerland J. Clin. Microbiol., June 1, 2005; 43(6): 2581 - 2585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-P. Ryser-Degiorgis, R. Hofmann-Lehmann, C. M. Leutenegger, C. H. af Segerstad, T. Morner, R. Mattsson, and H. Lutz EPIZOOTIOLOGIC INVESTIGATIONS OF SELECTED INFECTIOUS DISEASE AGENTS IN FREE-RANGING EURASIAN LYNX FROM SWEDEN J. Wildl. Dis., January 1, 2005; 41(1): 58 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Crawford, C. L. Swenson, S. P. Arnoczky, J. O'Shea, and H. Ross Lyophilization Does Not Inactivate Infectious Retrovirus in Systemically Infected Bone and Tendon Allografts Am. J. Sports Med., April 1, 2004; 32(3): 580 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Swenson and S. P. Arnoczky Demineralization for Inactivation of Infectious Retrovirus in Systemically Infected Cortical Bone: In Vitro and in Vivo Experimental Studies J. Bone Joint Surg. Am., January 29, 2003; 85(2): 323 - 332. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
